Table 1.
References | Year | Reported mortality | How CRP was integrated |
---|---|---|---|
Dequin et al. [6] | 2023 | 28-day and 90-day mortality | Reported in baseline, in subgroup analysis (threshold: 15 mg/dL) |
Meduri et al. [7] | 2022 | All-cause mortality at days 60, 180 and 365 | Not indicated |
Torres et al. [5] | 2015 | Death within 72 and 120 h of treatment, in-hospital mortality | Reported in baseline; clinical outcomes were compared between patients with a still high CRP (> 130 mg/L) at day 7 and those who were not |
Sabry et al. [8] | 2011 | Mortality by day 8 | Reported in baseline and was compared on day 2, 4, 6 and 8 |
El-Ghamrawy et al. [9] | 2006 | Reported mortality rate without specifying the type | Not indicated |
Confalonier et al. [10] | 2005 | Mortality by day 8, ICU mortality, hospital mortality and 60-day mortality | Reported in baseline and was compared on day 1, 2, 3, 6 and 8 |
Marik et al. [11] | 1993 | Reported mortality rate without specifying the type | Not indicated |
CRP C-reactive protein, ICU intensive care unit